Afficher la notice abrégée

dc.contributor.authorZapata Calvente, Antonella Ludmila 
dc.contributor.authorLópez Megías, Jesús 
dc.contributor.authorCaño Aguilar, África 
dc.contributor.authorSaeed Khan, Khalid 
dc.date.accessioned2022-05-09T10:54:11Z
dc.date.available2022-05-09T10:54:11Z
dc.date.issued2022-02-03
dc.identifier.citationAntonella Ludmila Zapata-Calvente... [et al.]. Screening for intimate partner violence during pregnancy: a test accuracy study, European Journal of Public Health, 2022;, ckac009, [https://doi.org/10.1093/eurpub/ckac009]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/74752
dc.descriptionThe study was funded by the Ministry of the Economy and Competitiveness of Spain (National Project IthornDthornI: FEM201679049-R). The funder had no part at any stage in analysis or in writing of this manuscript.es_ES
dc.description.abstractBackground Intimate partner violence (IPV) against women is a serious health problem that affects pregnancy more frequently than other obstetric complications usually evaluated in antenatal visits. We aimed to estimate the accuracy of the Women Abuse Screening Tool-Short (WAST-Short) and the Abuse Assessment Screen (AAS) for the detection of IPV during and before pregnancy. Methods Consecutive eligible mothers in 21 public primary health antenatal care centres in Andalusia (Spain) who received antenatal care and gave birth during January 2017-March 2019, had IPV data gathered by trained midwives in the first and third pregnancy trimesters. The index tests were WAST-Short (score range 0-2; cut-off 2) and AAS (score range 0-1; cut-off 1). The reference standard was World Health Organization (WHO) IPV questionnaire. Area under receiver operating characteristics curve (AUC), sensitivity and specificity with 95% confidence intervals (CI) were estimated for test performance to capture IPV during and before pregnancy, and compared using paired samples analysis. Results According to the reference standard, 9.5% (47/495) and 19.4% (111/571) women suffered IPV during and before pregnancy, respectively. For capturing IPV during pregnancy in the third trimester, the WAST-Short (AUC 0.73, 95% CI 0.63, 0.81), performed better than AAS (AUC 0.57, 95% CI 0.47, 0.66, P = 0.0001). For capturing IPV before pregnancy in the first trimester, there was no significant difference between the WAST-Short (AUC 0.69, 95% CI 0.62, 0.74) and the AAS (AUC 0.69, 95% CI 0.62, 0.74, P = 0.99). Conclusions The WAST-Short could be useful to screen IPV during pregnancy in antenatal visits.es_ES
dc.description.sponsorshipMinistry of the Economy and Competitiveness of Spain IthornDthornI: FEM201679049-Res_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleScreening for intimate partner violence during pregnancy: a test accuracy studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1093/eurpub/ckac009
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 3.0 España
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 3.0 España